newsfilter
← Latest News
Business Wire·

Magenta Therapeutics Announces $86.4 Million Common Stock Investment from Multiple Investors

Magenta Therapeutics, Inc. (NASDAQ:MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, announced that it has agreed to sell approximately 9,600,000 shares of its